MEDIFAST INC Cash Flow Statement
MED|13 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
MEDIFAST INC generated $7M in operating cash flow and $1M in free cash flow in FY2025. Free cash flow margin was 0.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$18.7M | $2.1M | $99.4M | $55.8M | $27.7M | $17.8M | $20.1M | $13.2M | $24.0M | $15.9M | $18.5M | $19.6M | $11.4M |
| Depreciation & Amortization | $14.2M | $12.7M | $13.1M | $4.4M | $4.2M | $5.4M | $7.1M | $8.1M | $7.9M | $8.4M | $8.3M | $5.9M | $5.3M |
| Operating Cash Flow | $6.9M | $24.5M | $147.7M | $60.8M | $43.2M | $25.4M | $29.4M | $25.5M | $42.4M | $40.3M | $34.9M | $28.8M | $19.2M |
| Capital Expenditures | $5.6M | $7.5M | $6.5M | $4.9M | $3.2M | $2.9M | $2.8M | $7.0M | $11.4M | $8.1M | $14.3M | $12.1M | $5.1M |
| Free Cash Flow | $1.2M | $17.0M | $141.2M | $55.9M | $40.0M | $22.5M | $26.6M | $18.5M | $31.0M | $32.1M | $20.6M | $16.7M | $14.0M |
| Share Buybacks | $0 | $0 | $3.6M | $30.0M | $30.0M | $30.0M | $10.5M | $33.9M | $20.1M | $2.8M | $20.4M | $35.0K | $102.0K |
| Dividends Paid | $195.0K | $715.0K | $73.0M | $23.2M | $15.4M | $11.9M | $11.9M | $11.9M | - | - | - | - | - |
| FCF Margin | 0.3% | 2.8% | 13.2% | 11.2% | 13.3% | 8.2% | 9.8% | 6.5% | 9.6% | 10.1% | 6.9% | 6.5% | 8.3% |